In addition, serum irisin concentration is stable in chronic CVD patients, but serum irisin concentration gradually decreases within 48 h after acute myocardial infarction (MI), suggesting that serum irisin concentration may have an important clinical value [137]. This evidence concerns the gene FNDC5 and myocardial infarction.